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ABSTRACT
Small, cysteine-rich, highly stable antifungal proteins
secreted by ﬁlamentous Ascomycetes have great po-
tential for the development of novel antifungal strate-
gies. However, their practical application is still limited
due to their not fully clariﬁed mode of action. The aim of
this work was to provide a deep insight into the anti-
fungal mechanism of Neosartorya ﬁscheri antifungal
protein (NFAP), a novel representative of this protein
group. Within a short exposure time to NFAP, reduced
cellular metabolism, apoptosis induction, changes in the
actin distribution and chitin deposition at the hyphal tip
were observed in NFAP-sensitive Aspergillus nidulans.
NFAP did show neither a direct membrane disrupting-
effect nor uptake by endocytosis. Investigation of
A. nidulans signalling mutants revealed that NFAP acti-
vates the cAMP/protein kinase A pathway via G-protein
signalling which leads to apoptosis and inhibition of
polar growth. In contrast, NFAP does not have any in-
ﬂuence on the cell wall integrity pathway, but an un-
known cell wall integrity pathway-independent mitogen
activated protein kinase A-activated target is assumed
to be involved in the cell death induction. Taken to-
gether, it was concluded that NFAP shows similarities,
but also differences in its mode of antifungal action
compared to two most investigated NFAP-related pro-
teins from Aspergillus giganteus and Penicillium
chrysogenum.
KEYWORDS Neosartorya ﬁscheri antifungal protein,
Aspergillus nidulans, cAMP/Pka signalling, Pkc/Mpk
signalling, antifungal mechanism
INTRODUCTION
The increased incidence of fungal infections and the fast
development of drug resistant ﬁlamentous fungi causing
mycoses, plant infections or damage to cultural heritages
strongly demand for the development of new antifungal
strategies. Antifungal peptides have great potential in
these ﬁelds, and also have signiﬁcant commercial potential
on the global market for antifungals set to be worth $12.2
billion by 2016 (Montesinos, 2007; Duncan and O’Neil,
2013).
In this respect, cysteine-rich antifungal proteins secreted
by ﬁlamentous Ascomycetes are promising candidates. The
Neosartorya ﬁscheri antifungal protein (NFAP) secreted by
N. ﬁscheri NRRL181 is a novel representative of this protein
group (Kovács et al., 2011). NFAP effectively inhibits the
growth of numerous ﬁlamentous Ascomycetes including
potential human and plant pathogens (Kovács et al., 2011;
Virágh et al., 2014). In our previous work we demonstrated
that NFAP interferes with the organization of the cell wall,
destroys the chitin ﬁlaments and triggers apoptotic/necrotic
events through reactive oxygen species accumulation in the
NFAP-sensitive Aspergillus nidulans (Galgóczy et al., 2013).
We also reported that Pichia pastoris KM71H produces
heterologous NFAP in an antifungally active and folded
state, and the antifungal effect is comparable to the native
protein (Virágh et al., 2014). In spite of these promising
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results, a detailed insight into the antifungal mechanism of
NFAP is still missing. This, however, represents essential
prerequisite for the practical application of NFAP. Therefore,
the antifungal mechanism of NFAP on A. nidulans was ex-
amined in more detail in the present study.
The following objectives were addressed in this work:
investigation of (i) the cell viability and apoptotic/necrotic
processes, (ii) the membrane permeabilization activity, and
(iii) the actin and chitin distribution in the presence of NFAP.
Furthermore, we examined the (iv) the localization of NFAP;
and (v) the signalling pathways involved in the mode of ac-
tion of NFAP.
RESULTS
Cell viability and apoptotic/necrotic events
in the presence of NFAP
The two-colour ﬂuorescent FUN1 stain passively diffuses into
the fungal cells and stains the cytoplasm and metabolically in-
active vacuoles green, while the metabolically active vacuoles
red. After short-time exposure to NFAP (30 min) reduced cel-
lular metabolismwas detected inA. nidulansFGSCA4hyphae
indicated by the presence of only green ﬂuorescent vacuoles
compared to the untreated control, which contained red
ﬂuorescent vacuoles too (Fig. 1A). This phenomenon was also
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Figure 1. Physiological changes in Aspergillus nidulans in the presence of Neosartorya ﬁscheri antifungal protein (NFAP).
(A) Viability staining of Aspergillus nidulans FGSC A4 hyphae with FUN-1 dye after NFAP treatment for 30 min at 37°C. Red vacuoles
A indicates metabolic activity, while green vacuoles B metabolic inactivity. (B) Propidium iodide (PI) staining of A. nidulans FGSC A4
hyphae after NFAP treatment for 16 h at 37°C. Intracellular red ﬂuorescence indicates membrane disruption. (C) Actin distribution at
A. nidulans Actin-GFP hyphal tips in response to NFAP treatment for 30 min at 30°C. C: actin patch. (D) Calcoﬂuor white (CFW)
staining of A. nidulans FGSC A4 hyphae after NFAP treatment for 30 min at 37°C. D: cap-like CFW ﬂuorescence - site of the chitin
assembly, E: lack of the cap-like CFW ﬂuorescence, F: delocalized chitin deposition. C: untreated control, C + : positive PI staining
control-hypha was treated with 70% Et-OH for 1 h at 4°C, NFAP: NFAP-treated (25 µg/mL) hyphae. Upper images, light microscopy;
lower images, ﬂuorescence microscopy of PI staining (B) and of actin distribution (C).
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observed after 60 min and 16 h of NFAP-treatment (data not
shown).
Annexin V-FITC Apoptosis Detection Kit dyes the apop-
totic cells green, while the necrotic cells are counterstained
red. Living cells do not show any ﬂuorescence. After 30 and
60 min a signiﬁcant increase in the number of apoptotic 16 h-
old germlings was observed in the NFAP-treated samples
(26.1 ± 7.5% and 31.8 ± 8.8%, respectively; P < 0.0001)
compared the untreated control where only a few percent of
the cells (2.2 ± 1.3%) showed green ﬂuorescence. Only few
necrotic cells were detected in the untreated (5.1 ± 1.9%)
and NFAP-treated samples after 30 min (4.8 ± 3.7%) and
60 min (5.2 ± 0.9%). These results suggest that NFAP exerts
its antifungal effect through induction of apoptosis. After
16 h, however, almost all germlings (98.9 ± 1.1%) showed
red ﬂuorescence which indicated the death of the cells.
NFAP does not cause direct membrane disruption
The membrane disrupting activity of NFAP was investigated
by applying the membrane impermeant, red-ﬂuorescent nu-
clear and chromosome stain propidium iodide (PI). This dye
can penetrate only into the dead cells where the membrane
integrity is damaged. Most of the A. nidulans FGSC A4 hy-
phae did not show any red ﬂuorescence after a 30- and
60-min-long incubation in the presence of NFAP (data not
shown). This indicates that the plasma membrane was still
intact at these time points, similarly to the untreated control.
After 16 h almost only red ﬂuorescent hyphae appeared in
the NFAP-treated sample pointing towards a massive
membrane disruption as a consequence of the long-time cell
killing effect of NFAP (Fig. 1B).
Changes in the actin distribution and chitin deposition
at the hyphal tip
To study the morphological aberrations of NFAP-exposed
A. nidulans hyphae we analysed the actin distribution and
the deposition of chitin at the hyphal tips. Actin-GFP ex-
pressing A. nidulans showed typical actin patch distribution
at the hyphal tips clustered near the apical region and
scattered behind the tips (Taheri-Talesh et al., 2008)
(Fig. 1C). In contrast, actin patches were disturbed in hyphae
that were treated with NFAP for 30 min only (Fig. 1C). Cal-
coﬂuor white (CFW) staining revealed delocalized chitin
deposition at hyphal tips of A. nidulans FGSC A4 after NFAP
treatment for 30 min. In contrast, the untreated control
sample exhibited a characteristic cap-like CFW ﬂuorescence
(Fig. 1D). These effects in actin and chitin delocalization
were also observed after 60 min and 16 h of incubation with
NFAP (data not shown). These results indicate that in the
presence of NFAP the normal actin polarization/localization
and chitin distribution are disturbed in A. nidulans.
NFAP shows no active internalization
A produced polyclonal NFAP-antiserum reacted speciﬁcally
with NFAP, and no signals were obtained with the control
serum that was collected before the ﬁrst injection (data not
shown). An indirect immunoﬂuorescence staining method
was applied to study the localization of NFAP in A. nidulans
FGSC A4. NFAP did not enter the fungal cell in detectable
concentration levels after 30 and 60 min of exposure (data
not shown), but after 16 h NFAP-speciﬁc ﬂuorescence sig-
nals accumulated at hyphal fractures, twists and in cell-wall
bubbles (Fig. 2A). To clarify whether the NFAP internalization
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Figure 2. Localization of Neosartorya ﬁscheri antifungal protein (NFAP) in Aspergillus nidulans. (A) Indirect immunoﬂuores-
cence staining of Aspergillus nidulans FGSC A4 hyphae with rat anti-NFAP serum and FITC-conjugated swine anti-rat IgG, after
NFAP treatment for 16 h at 37°C. NFAP accumulation in A: hyphal fracture and twist; B: cell-wall bubble. C: untreated control, NFAP:
NFAP-treated (25 µg/mL), NFAP + latB: NFAP- (25 µg/mL) and latrunculin B- (5 µg/mL) treated hyphae. (B) Propidium iodide (PI)
staining of Aspergillus nidulans FGSC A4 hyphae after 25 µg/mL NFAP treatment for 90 min at 37°C. Red ﬂuorescence at hyphal
bubble C and around hyphal fracture D indicates membrane disruption and outﬂow of the hyphal/cell content. Upper images, light
microscopy; lower images, ﬂuorescence microscopy of indirect immunoﬂuorescence staining (A) and of PI staining (B).
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was the consequence of an endocytic mechanism, the
indirect immunoﬂuorescence staining was repeated in the
presence of 5 µg/mL latrunculin B (latB). LatB selectively
inhibits the actin polymerization and therefore disturbs en-
docytosis. If the NFAP accumulation in the hyphae after 16 h
is a consequence of an endocytotic mechanism no ﬂuores-
cence signal should be observable in the cell. NFAP-speciﬁc
ﬂuorescence signals appeared in hyphae only after 16 h of
incubation with NFAP and latB, but not after the exposure for
30 or 60 min (Fig. 2A). Based on these results, we conclude
that NFAP is presumably not internalized by endocytosis.
Instead, the accumulation of NFAP after 16 h is possibly a
consequence of a passive diffusion at disrupted sites of the
cell wall and plasma membrane.
NFAP interferes with the G-protein signal transduction
and cell wall integrity pathways in Aspergillus nidulans
NFAP activates the cAMP/Pka signalling cascade through
heterotrimeric G-protein
The A. nidulans FGSC1035 strain carries a dominant
negative mutation in the guanidine nucleotide binding do-
main of heterotrimeric G-protein α-subunit (fadA). As a
consequence of this mutation the ability of the Gα subunit to
dissociate from Gβγ is inhibited causing constitutive inacti-
vation of heterotrimeric G-protein signalling (Yu et al., 1996).
Growth inhibition assays revealed that FGSC1035 strain
was less susceptible to NFAP than its isogenic recipient
FGSC116 strain indicating that G-protein signalling is nec-
essary for NFAP toxicity (Table 1). In A. nidulans the cAMP/
protein kinase A (Pka) pathway is activated by heterotrimeric
G-protein signalling, and it is involved in the regulation of
morphological development (Shimizu and Keller, 2001), and
in the induction of apoptosis (Semighini et al., 2006). To in-
vestigate if cAMP/Pka signalling plays a role in the
mechanism of action of NFAP, we tested the susceptibility of
an A. nidulans strain with depleted Pka activity (Shimizu and
Keller, 2001). The pkaA deletion mutant exhibited reduced
sensitivity towards NFAP compared to its recipient RKIS1
strain suggesting that NFAP activates the cAMP/Pka sig-
nalling cascade and possibly promotes programmed cell
death (PCD) (Table 1). Our assumption was further sup-
ported by susceptibility tests applying NFAP in combination
with 8-bromoadenosine 3’,5’-cyclic monophosphate (8-Br-
cAMP) and caffeine on strain FGSC A4. 8-Br-cAMP is an
activator of cAMP/Pka signalling in fungi (Gorovits and Yar-
den, 2003), while caffeine represses the Pka signalling by
reduction of cAMP levels (Kuranda et al., 2006). NFAP ag-
gravated the toxicity of 8-Br-cAMP indicating a synergistic
interaction between the two compounds and an activating
effect of NFAP in cAMP/Pka signalling (Table 2). In contrast,
caffeine ameliorated the growth of FGSC A4 strain exposed
to NFAP (Table 2). The ΔpkaA strain, however, showed hy-
persensitivity (63% ± 6.5% growth) to 20 mmol/L caffeine
compared to its recipient RKIS1 strain (91% ± 6.8% growth).
This growth reduction induced by caffeine was cured by the
addition of NFAP and overgrowth was detected compared to
the untreated control (Table 2). These results suggest that
NFAP and caffeine act in an opposite manner on Pka sig-
nalling. The overgrowth effect may be explained by the re-
sponse of the fungus that activates rescue mechanisms
against the co-administration of two antifungals, which have
different cellular targets (Ouedraogo et al., 2011).
It is worth to mention here that FGSC A4 and Actin-GFP
strains showed the same changes in chitin deposition and the
Table 1. Growth percentages of the investigated Aspergillus nidulans strains in presence of different concentrations of NFAP in
in vitro broth microdilution test after 48 h of incubation at 30°C or 37°C (depending on the investigated strain)
NFAP/Strain 200 µg/mL 100 µg/mL 50 µg/mL Type
RhoAG14V 48 % ± 15.2%ns 57% ± 4.5%ns 86% ± 12.5%ns Mutant
ΔmpkA 108% ± 9.1%*** 105% ± 6.7%*** 103% ± 0.9%** Mutant
GR5 47% ± 7.5% 58% ± 5.4% 83% ± 11.9% Isogenic recipient of RhoAG14V and ΔmpkA
alcA-PkcAa 48% ± 10.6%*** 57% ± 0.6%*** 64% ± 12.5%*** Mutant
alcA-PkcAb 74% ± 7.6%ns 77% ± 0.5%ns 99% ± 0.2%ns Mutant
R153 72% ± 2.8% 83% ± 4.4% 102% ± 1.8% Isogenic recipient of alcA-Pkca
ΔpkaA 56% ± 6.1%*** 69% ± 5.3%*** 83% ± 11.5%** Mutant
RKIS 1 40% ± 2.7% 48% ± 1.6% 66% ± 4.0% Isogenic recipient of ΔpkaA
FGSC 1035 52% ± 1.9%* 78% ± 0.2%*** 101% ± 0.4%*** Mutant
FGSC 116 42% ± 6.7% 59% ± 1.9% 75% ± 2.3% Isogenic recipient of FGSC 1035
The untreated control is taken as 100% of growth. The mean growth percentages and their standard deviations from three replicates (n = 3) are
indicated in the cells. Signiﬁcant differences (P-values) were determined based on the comparison with the growth percentages of parental
strain. ***: P < 0.0001; **: P < 0.005; *: P < 0.05; ns: no signiﬁcant differences. NFAP: Neosartorya ﬁscheri antifungal protein.
a A. nidulans alcA-PkcA in the presence of glucose.
b A. nidulans alcA-PkcA in the presence of glycerol.
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actin distribution after 60 min of exposure to 5 mmol/L 8-Br-
cAMP (Fig S1a andS1b) as it was observed in the presence of
NFAP (Fig. 1D and 1C). In contrast to the FGSC A4 strain
(Fig. 1D), chitin delocalization was not observed in the fadA
and ΔpkaA mutants when they were treated with 25 µg/mL
NFAP for 30 min (Fig S2a and S2b). These observations fur-
ther strengthen the role of the NFAP in the inhibition of polar
growth and chitin assembly via cAMP/Pka signalling.
NFAP acts on an unknown cell wall integrity pathway-
independent mitogen-activated protein kinase
A-downstream target
RhoA is an essential protein for polar growth, branching, and
cell wall synthesis in A. nidulans (Guest et al., 2004). The
RhoAG14V mutant with ectopic copies of the constitutively
active rhoAG14Vallele showed thesamesusceptibility toNFAP
and to the cell wall stressing agent CFWas its isogenic control
GR5 strain (Table 1 and Table 3), but proved to be less sus-
ceptible to caffeine (Table 3). These results demonstrate that
RhoA is not directly involved in NFAP toxicity, and NFAP may
target the downstreameffectors ofRhoA, e.g. protein kinaseC
(Pkc). Pkc plays an important role in suppression of apoptosis
through activation of the mitogen-activated protein kinase
(Mpk) cascade, and also in polarity establishment indepen-
dently of the Mpk cascade during germination in A. nidulans
(Katayama et al., 2012). To investigate a possible role of Pkc/
Mpk signalling in NFAP antifungal activity, we tested a condi-
tionalA. nidulans alcA-PkcAmutant for NFAP susceptibility. In
this mutant, the expression of PkcA was repressed by glu-
cose, but induced by glycerol (Ronen et al., 2007). There was
no signiﬁcant difference (P > 0.05) between the growth of this
strain at differentNFAPconcentrations underPkcA repressing
conditions in contrast to the isogenic recipient A. nidulans
R153 (P < 0.0001) (Table 1). In the presence of glycerol the
alcA-PkcAmutant showed the same susceptibility to NFAP as
the R153 strain, and signiﬁcant differences between the
growth percentages at different NFAP concentrations were
observed (P < 0.0001) (Table 1). These results suggest that
NFAP has no inﬂuence on the PkcA signalling, which affects
Table 2. Growth percentages of Aspergillus nidulans strains in presence of NFAP and NFAP-8 Br-cAMP/caffeine combinations in
in vitro broth microdilution test after 48 h of incubation at 37°C
NFAP/other compounds 0 µg/mL 50 µg/mL 100 µg/mL 200 µg/mL
FGSC A4
NFAP 100% 91% ± 6.0% 67% ± 6.7% 52% ± 3.2%
NFAP + 5 mmol/L 8-Br-cAMP 70% ± 1.6% 58% ± 4.2%*** 57% ± 3.8%*** 41% ± 3.2%***
NFAP + 20 mmol/L caffeine 71% ± 2.1% 74% ± 3.7%ns 61% ± 2.6%*** 108% ± 1.5%***
ΔpkaA
NFAP 100% 83% ± 11.5% 69% ± 5.3% 56% ± 6.1%
NFAP + 20 mmol/L caffeine 63% ± 6.5% 123% ± 7.9%*** 195% ± 30.6%*** 196% ± 3.0%***
The untreated control is taken as 100% of growth. The mean growth percentages and their standard deviations from three replicates (n = 3) are
indicated in the cells. Signiﬁcant differences (P-values) were determined based on the comparison with the growth percentages in the presence
of 8-Br-cAMP or caffeine alone. ***: P < 0.0001; ns: no signiﬁcant differences. 8-Br-cAMP: 8-bromoadenosine 3’,5’-cyclic monophosphate,
NFAP: Neosartorya ﬁscheri antifungal protein.
Table 3. Growth percentages of Aspergillus nidulans strains in presence of caffeine and CFW in in vitro broth microdilution test after
48 h of incubation at 30°C or 37°C (depending on the investigated strain)
Compounds/
strain
Caffeine CFW Type
10 mmol/L 20 mmol/L 10 µg/mL 20 µg/mL
RhoAG14V 78% ± 1.2%*** 60% ± 8.4%* 92% ± 7.1%ns 55% ± 7.7%ns Mutant
ΔmpkA 17% ± 3.9%*** 15% ± 2.6%*** 76% ± 2.5%*** 49% ± 4.0%** Mutant
GR5 59% ± 1.1% 48% ± 2.7% 97% ± 2.1% 60% ± 3.3% Isogenic recipient of RhoAG14V
and ΔmpkA
alcA-PkcA 29% ± 0.3%*** 21% ± 4.4%*** 44% ± 5.9%*** 22% ± 5.2%*** Mutant
R153 87% ± 2.9% 79% ± 14.4% 95% ± 3.0% 74% ± 2.6% Isogenic recipient of alcA-Pkca
The untreated control is taken as 100% of growth. The mean growth percentages and their standard deviations from three replicates (n = 3) are
indicated in the cells. Signiﬁcant differences (P-values) were determined based on the comparison with the growth percentages of parental
strain. ***: P < 0.0001; **: P < 0.005; *: P < 0.05, ns: no signiﬁcant differences. CFW: calcoﬂuor white.
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polarity establishment and induces apoptosis suppression
(Katayama et al., 2012). Further evidence was gained by us-
ing a MpkA deletion mutant. MpkA is involved in the polarized
growth ofA. nidulansand the cell wall integrity (CWI) signalling
pathway (Bussink and Osmani, 1999; Fujioka et al., 2007).
Cell wall stressing agents (such as caffeine and CFW) induce
the CWI pathway by increasing the Pkc and Mpk phosphory-
lation in A. nidulans (Fujioka et al., 2007). Indeed, we could
show that the alcA-PkcA and ΔmpkA strains were hypersen-
sitive to caffeine and CFW compared to their isogenic control
strains R153 and GR5 (Table 3). The ΔmpkA strain, however,
exhibited resistance to NFAP, while the recipient GR5 strain
was susceptible (Table 1). This observation suggests that
NFAP does not interfere directly with the activation of MpkA,
but may affect a CWI pathway-independent MpkA-activated
unknown target playing a role in the antifungal effect of NFAP.
NFAP does not activate cell wall integrity pathway
Based on our results we hypothesized that NFAP does not
activate the CWI pathway by activation of downstream tar-
gets. To prove this assumption we investigated the sensitivity
of A. nidulans FGSC A4 strain towards 100 µg/mL CFW, and
100 µg/mL CFW in combination with 200 µg/mL NFAP. CFW
induces the CWI pathway by activation of the Rho/Pkc/Mpk
signalling cascade in A. nidulans (Fujioka et al., 2007). In the
presence of CFW and NFAP alone, this strain showed
9% ± 0.3% and 52% ± 3.2% growth, respectively; while
signiﬁcant increase in the growth was detected in combina-
tion of the two compounds (61.3% ± 1.3%, P < 0.0001). This
ameliorated growth effect indicates that CFW and NFAP
antagonize each other, and NFAP does not activate the CWI
pathway; however, further experiments (e.g. investigation of
CWI gene expression) are needed for veriﬁcation of this
assumption.
DISCUSSION
From the 1990s several extracellular cysteine-rich proteins
with remarkable antifungal activity against moulds have
been isolated and characterized from ﬁlamentous As-
comycetes. The antifungal mode of action is extensively
studied only in the case of three representatives, the
Aspergillus giganteus antifungal protein (AFP) (Meyer,
2008), the A. giganteus A3274 antifungal protein (AFPNN5353
a very similar protein to AFP) (Binder et al., 2011) and the
Penicillium chrysogenum antifungal protein (PAF) (Hegedus
et al., 2011). Results presented in this study allow us to
compare the detailed antifungal mechanism of NFAP with
these proteins. By studying an NFAP-producing A. nidulans
strain we previously proved that NFAP interferes with the
organization of the cell wall, destroys the chitin ﬁlaments as it
was observed also in the case of AFP, and triggers apop-
totic-necrotic events through ROS accumulation as de-
scribed for PAF (Galgóczy et al., 2013). However, it was not
clariﬁed whether these changes are the primary, short-time
effect of the NFAP or if they are the consequences of its
secondary, cell-killing effect.
NFAP caused metabolic inactivation and induced apop-
totic cell death in A. nidulans, but no plasma membrane
disruption could be observed within one hour of exposure.
This observation is comparable with our previous ﬁnding
when majority of the NFAP-producing A. nidulans germlings
showed apoptotic phenotype after 8 h of cultivation sug-
gesting the signiﬁcance of apoptosis-inducing effect for an-
tifungal activity (Galgóczy et al., 2013). Previously, it was
proved that PAF evokes metabolic inactivity in Aspergillus
niger (Kaiserer et al., 2003), and a PCD-like phenotype in
A. nidulans (Leiter et al., 2005). Plasma membrane disrup-
tion by AFP was detected in A. niger (Theis et al., 2003).
Similar to our investigations with NFAP, disordered actin
patch distribution, reduced chitin content and delocalized
chitin deposition at the hyphal tips were also observed pre-
viously when A. nidulans was treated with PAF (Binder et al.,
2010). During the polarized growth of A. nidulans exocytic
vesicles (containing cell wall biosynthetic enzymes and wall
precursors) and endocytic recycling vesicles are delivered
by myosin molecules on actin cables to and from the hyphal
tip. Therefore actin functions in the spatially coupled exo-
and endocytosis at the tip and in holding the tip apparatus
together (Taheri-Talesh et al., 2008). Since the correct lo-
calization of actin ﬁlaments is essential for polarized growth,
the random distribution of actin as a consequence of NFAP
treatment results in disturbed apical growth which leads to
the previously well-described hyperbranching, swollen hy-
phal tips and destructed cell wall of the sensitive fungus in
the presence of NFAP (Kovács et al., 2011; Galgóczy et al.,
2013) (Fig. S3).
The indirect immunoﬂuorescence staining experiments
revealed that NFAP is internalized by passive transport
across the disrupted sites of the plasma membrane and cell
wall, not by an endocytotic uptake. The membrane disruption
at hyphal fractures and bubbles where NFAP is accumulated
after 16 h of treatment were conﬁrmed by PI staining. These
sites showed intensive red ﬂuorescence indicating the loss
of membrane integrity after more than one hour of incubation
with NFAP (Fig. 2B). In contrast to NFAP, PAF and
AFPNN5353 are internalized by endocytosis and distributed in
the cytoplasm of A. nidulans (Oberparleiter et al., 2003;
Binder et al., 2011), while AFP accumulates only in the outer
layer, the cell wall and/or the plasma membrane of A. niger
(Theis et al., 2003, 2005).
Based on the above mentioned observations NFAP may
get into the cell within 30 min in a concentration below the
detectable level which might be enough to interfere with the
actin localization and chitin distribution and to cause apop-
tosis. It could be also possible that these effects are sec-
ondary consequences of the NFAP action: NFAP may bind
to a surface receptor which activates a signalling pathway
that leads to apoptosis and defective polar growth. The
susceptibility tests with A. nidulans signalling mutants indeed
point towards signalling pathways affected by NFAP.
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The antifungal mechanism of NFAP proved to be inde-
pendent from the RhoA and PkcA, members of the CWI
pathway. The small GTPase RhoA is an essential protein
involved in the polar growth (Guest et al., 2004). PkcA plays
a role in the polarity establishment independently of MpkA
(Katayama et al., 2012) and in the suppression of apoptosis
via MpkA (Katayama et al., 2012) (Fig. 3). Similarly, the
toxicity of the P. chrysogenum antifungal protein PAF was
also shown to be independent from RhoA, instead inhibition
of RhoA-GAP targets was supposed (Binder et al., 2010). In
contrast to NFAP, PAF possibly inactivates the Pkc signalling
(Binder et al., 2010). Binder et al. (2011) suggested that the
toxicity of AFPNN5353 is transmitted by RhoA-GAP targets
and not by RhoA itself. The role of RhoA-GAP targets in the
NFAP toxicity is awaiting further investigations. In our study
NFAP did not induce the CWI pathway in A. nidulans similar
to PAF (Binder et al., 2010). In contrast, AFP and AFPNN5353
activates the CWI pathway by increasing the MpkA/RlmA-
activated α-glucan synthase agsA expression, a main en-
zyme in the cell wall remodelling of A. niger (Hagen et al.,
2007; Binder et al., 2011) (Fig. 3).
Our results indicate that NFAP might bind to a G-protein
coupled receptor similarly to other antifungal proteins and
drugs (Van Dijck, 2009; Hegedüs and Marx, 2013) that re-
sults in the induction of the cAMP/Pka cascade, which in-
hibits the polar growth (Bencina et al., 2005) and modulates
PCD (Semighini et al., 2006) (Fig. 3). Similar to NFAP, PAF
also activates the cAMP/Pka signalling cascade via the
heterotrimeric G-protein signal transduction pathway (Binder
et al., 2010). The identiﬁcation of a G-protein coupled re-
ceptor of NFAP would further accelerate the elucidation of
the mechanism of its antifungal activity.
Presumably, activation of a cell wall integrity pathway-
independent, but MpkA-dependent unknown factor, which
induces PCD, may also play a role in the antifungal
mechanism of NFAP (Fig. 3). This latter assumption is sup-
ported by the report of the existence of an MpkA-mediated
cell death pathway in A. nidulans by Colabardini et al.
(2010). This group observed an increased tolerance of the
A. nidulans ΔmpkA strain to farnesol-induced cell death
compared to ΔmpkC and ΔhogA strains. Proving the exis-
tence of this MpkA-activated apoptosis factor is waiting for
further investigations. In contrast to NFAP, PAF fails to acti-
vate the Mpk (Binder et al., 2010), and AFPNN5353 evokes
growth inhibition via activation of Pkc/Mpk signalling path-
way in A. nidulans (Binder et al., 2011).
The features of the cysteine-rich antifungal proteins ren-
der them exceptionally suitable compounds as commercial
preservatives, bio-pesticides and drugs against moulds and
offer an alternative, safely applicable solution for the recent
antifungal challenges (Marx et al., 2008; Meyer, 2008). Our
present results signiﬁcantly contribute to the understanding
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Figure 3. Tentative model for the antifungal mechanism of Neosartorya ﬁscheri NFAP in Aspergillus nidulansmodiﬁed from
Binder et al. (2010; 2011) for Penicillium chrysogenum PAF and Aspergillus giganteus A3274 AFPNN5353, respectively. 8-Br-
cAMP: 8-bromoadenosine 3’,5’-cyclic monophosphate, AC: adenylate cyclase, cAMP: cyclic adenosine monophosphate, CFW:
calcoﬂuor white, Mpk: mitogen activated protein kinase, Pka: protein kinase A, Pkc: protein kinase C, RhoA: small GTP binding
protein, RlmA: transcription factor, TFs: transcription factors.
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of the antifungal mechanism not only of NFAP, but also of
other cysteine-rich antifungal proteins from Ascomycetes in
general.
MATERIALS AND METHODS
Strains and media
A. nidulans strains used in the present study are listed in Table 4. All
signalling mutants, their isogenic recipients, and the actin-GFP strain
were grown and maintained in minimal medium (MM, Ronen et al.,
2007) with respective supplementation (Bussink and Osmani, 1999;
Shimizu and Keller, 2001; Guest et al., 2004, Ronen et al., 2007;
Taheri-Talesh et al., 2008). The Glasgow wild type A. nidulans FGSC
4A was grown and maintained in complete medium (CM, Kuranda
et al., 2006).
NFAP production and puriﬁcation
Heterologous expression and puriﬁcation of NFAP was carried out in
P. pastoris KM71H as described previously (Virágh et al., 2014).
Microscopic investigation
Microscopic investigation of the NFAP-speciﬁc antifungal effect was
carried out on A. nidulans FGSC A4 and A. nidulans actin-GFP
conidia (105 conidia/mL) which were immobilised on cover slips, and
incubated in CM at 37°C (or at 30°C in case of A. nidulans actin-GFP
strain) for 16 h. For the investigation of the short-time antifungal
effect, cover slips were treated with CM supplemented with sublethal
concentration of NFAP (25 µg/mL) for 30 and 60 min at 37°C (or at
30°C in case of A. nidulans actin-GFP strain). CM without NFAP was
used as control. To reveal the long-time antifungal effect cover slips
were incubated in the presence of NFAP for 16 h at 37°C (or at 30°C
in case of A. nidulans actin-GFP strain).
Germinated conidia and/or hyphae were examined and pho-
tographed with a light microscope with ﬂuorescence lamp (LR
66238C, Carl Zeiss, Axiolab) equipped with a digital microscope
camera (AxioCam ERc 5s, Carl Zeiss, Axiolab). All experiments
were repeated three times.
Viability staining and detection of apoptotic/necrotic events
To compare the metabolic activity of NFAP-treated and untreated
A. nidulans FGSC A4 hyphae and to reveal the apoptotic/necrotic
events, FUN1 viability staining (Invitrogen-Life Technologies, Eu-
gene, OR, USA) and Annexin V-FITC Apoptosis Detection Kit
(Sigma-Aldrich, St. Louis, MO, USA) were adapted to cover slips,
respectively. After incubation, the hyphae on cover slips were
washed with 10 mmol/L HEPES pH = 7.5 (Sigma-Aldrich, St. Louis,
MO, USA), then incubated for 30 min at 37°C in 10 mmol/L HEPES
containing 2% (w/v) glucose (pH = 7.5), and stained with 5 µmol/L
FUN1 stain diluted in 10 mmol/L HEPES pH = 7.5 in the dark at room
temperature for 30 min, and ﬁnally, washed again with 10 mmol/L
HEPES supplemented with 2% (w/v) glucose (pH = 7.5). In case of
the Annexin V-FITC Apoptosis Detection Kit the hyphae on cover
slips were washed with CM and stained with PI and Annexin V-FITC
diluted in binding buffer in the dark at room temperature for 10 min,
and then washed again with CM.
Detection of membrane disruption
PI staining was used to observe NFAP-speciﬁc membrane disruption
on A. nidulans FGSC A4. Cover slips treated with 70% (v/v) ethanol
for 30 min at 4°C were used as positive staining controls. After
washing with CM cover slips were stained with 5 µg/mL PI for 10 min
at room temperature in the dark, and then washed again with CM.
Analysis of actin distribution and chitin content
To investigate the impact of NFAP on the actin distribution a derivate
of the A. nidulans GR5 strain was used, which carries an additional
copy of actin tagged with green ﬂuorescent protein on its N-terminus
(Taheri-Talesh et al., 2008). Chitin content of the A. nidulans FGSC
A4 in the presence of NFAP was visualized with CFW staining
(Sigma-Aldrich, St. Louis, MO, USA). Cover slips were washed with
Table 4. Investigated Aspergillus nidulans strains and their genotype
Strain Relevant genotype Reference or source
FGSC A4 Glasgow wild type FGSC
FGSC 116 yA2 FGSC
FGSC 1035 yA2 fadAG203R FGSC
R153 wA2; pyroA4 Ronen et al. (2007)
alcA-PkcA wA2; pyroA4; pyrG89::pyr4alcA(p)::pkcAΔp Ronen et al. (2007)
GR5 pyrG89; wA3; pyroA4 Guest et al. (2004)
RhoAG14V A773 + pGG2 (rhoAG14) and pRG3AMA1 (co-transformation plasmid) Guest et al. (2004)
ΔmpkA ΔmpkA Bussink and Osmani (1999)
RKIS1 papaA1; yA2 Shimizu and Keller (2001)
ΔpkaA papaA1; yA2; ΔpkaA::argB; ΔargB::trpC; trpC801; veA1 Shimizu and Keller (2001)
Actin-GFP wA3; pyroA4; actin_GFP::pyrG (pyr G 89) Taheri-Talesh et al. (2008)
FGSC: Fungal Genetics Stock Center, Kansas, MO, USA.
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CM, then stained with 10 µmol/L CFW at room temperature in the
dark for 10 min, and ﬁnally, washed again with CM.
Generation and testing of anti-NFAP polyclonal sera
Two-months-old female WISTAR rats were immunized with 100 μg
NFAP in complete, then twice in incomplete Freund’s adjuvant. The
animal experiments we performed according to institutional and
national ethical guidelines, in possession of ethical clearances. In-
dividual sera from three rats were screened by Western blotting, and
the serum with the strongest speciﬁc signal was used in further
experiments. For the screening of the sera, puriﬁed NFAP was
separated by SDS-PAGE (XCell SureLock Mini-Cell, Invitrogen-Life
Technologies, Eugene, OR, USA) and transferred onto PVDF
membranes (Immobilon-P, IPVH00010, Millipore, Billerica, MA,
USA). Membrane was incubated overnight at 4°C with NFAP-im-
munized rat serum (1:100), washed three times, and then incubated
with horseradish peroxidase conjugated anti-rat secondary antibody
(1:1000; R&D, Minneapolis, MN, USA). Immunoreactive signals
were developed using Supersignal West Pico Chemiluminscent
Substrates (Thermo Scientiﬁc, MR, USA) and detected with LI-COR
ODYSSEY® Fc (Dual-mode imaging system) imager followed by
analysis with Odyssey v1.2 software.
Immunoﬂuorescence staining
Localization of NFAP in A. nidulans FGSC A4 was investigated
using an indirect immunoﬂuorescence staining method described by
Fischer and Timberlake (1995). Cover slips with germlings were
transferred to a solution containing 50 mmol/L PIPES (pH = 6.7),
25 mmol/L EGTA, 5 mmol/L MgSO4, 5% (v/v) dimethyl sulfoxide, 8%
(v/v) formaldehyde. After this ﬁxation step, cover slips were washed
four times with PEM buffer (50 mmol/L PIPES pH = 6.7, 25 mmol/L
EGTA, 5 mmol/L MgSO4). For wall digestion coverslips were trans-
ferred to PEM buffer containing Glucanex (500 mg/mL; Sigma-
Aldrich, St. Louis, MO, USA) and incubated at room temperature for
2 h, then washed four times in PEM buffer (pH = 6.7) and transferred
into an extraction solution containing 100 mmol/L PIPES (pH = 6.7),
20 mmol/L EGTA, 0.1% (v/v) Triton X-100. After this treatment the
cover slips were incubated in the presence of rat anti-NFAP serum
diluted 1:600 in Tris-buffered saline containing bovine serum albu-
min (TBS/B, 20 mmol/L Tris-HCl pH = 8.0, 20 mmol/L NaCl, 0.1%
(v/v) Tween-20, 3% (v/v) bovine serum albumin (Sigma-Aldrich, St.
Louis, MO, USA)) for 60 min. Immunocomplexes were detected with
FITC-conjugated goat-anti-rat-IgG (Sigma-Aldrich, St. Louis, MO,
USA) diluted 1:40 in TBS/B. For studying the uptake mechanism of
NFAP, immunoﬂuorescence staining was performed after treatment
of the samples with NFAP and 5 µg/mL latB (inhibitor of actin
polymerization; Sigma-Aldrich, St. Louis, MO, USA). As a positive
control, indirect immunoﬂuorescence staining was repeated with
monoclonal mouse anti-actin antibody (Sigma-Aldrich, St. Louis,
MO, USA) and polyclonal rabbit anti-mouse immunoglobulins/TRITC
(Agilent Technologies, Dako Denmark A/S, Glostrup, Denmark).
Growth inhibition assay
Theantifungal effect ofNFAP (25–200µg/mL), 8-Br-cAMP (5mmol/L),
CFW (10, 20, and 100 µg/mL), and caffeine (10 and 20 mmol/L) (all
fromSigma-Aldrich, St. Louis,MO, USA)was investigated in a 96-well
microtiter plate bioassay on A. nidulans strains in CM or MM con-
taining 105 conidia/mL and supplemented with the required ingredi-
ents for the growth of certain strains (Bussink and Osmani, 1999;
ShimizuandKeller, 2001;Guest et al., 2004,Ronenet al., 2007). In the
combination experiments 100 μL aliquots of a serial NFAP dilution
(50–200µg/mL) containing2×105 conidia/mLweremixedwith 100μL
100 µg/mL CFW, 5 mmol/L 8-Br-cAMP, or 20 mmol/L caffeine at ﬁnal
concentrations in the wells. Plates were incubated at the optimal
temperature of the tested strain for 48 h without shaking and then the
absorbances (OD620) were measured after gently shaking for two
seconds with a microtiter plate reader in well scanning mode
(SPECTROstar Nano, BMG Labtech, Ortenberg, Germany) (Tables
S1, S2, and S3). Fresh medium was used for background calibration.
For calculation of the growth rates, the absorbances of the untreated
control cultures were set to be 100% growth. All susceptibility tests
were repeated three times.
Statistical analysis
All statistical analyses were performed using GraphPad Prism ver-
sion 5.01 for Windows (GraphPad Software, San Diego, CA, USA).
The signiﬁcant differences between sets of data were determined by
One-way analysis of variance with Bonferroni’s multiple comparison
posttest according to the data.
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